Smithers extends accreditation scope for medical device testing

By Melissa Fassbender contact

- Last updated on GMT

(Image: iStock/Ca-ssis)
(Image: iStock/Ca-ssis)

Related tags: United kingdom

Testing services provider Smithers Pira has extended its ISO/IEC 17025:2005 scope of accreditation for medical devices.

Smithers Pira, one of six companies that make up The Smithers Group, provides market intelligence and testing services at facilities in the UK and US.

The United Kingdom Accreditation Service (UKAS) accreditation covers the company’s dedicated medical device testing facility in Shawbury, UK, which was opened in December 2016.

According to the company, accreditation by UKAS to ISO/IEC 17025:2005 recognizes Smithers “competence, impartiality, and reliability in its ability to deliver results​.”

The extended UKAS scope of accreditation covers vials, prefilled syringes, needle-based injection systems, and syringes.

Good Manufacturing Practices

Smither Pira also announced that the Shawbury facility is compliant with current Good Manufacturing Practices (cGMP) in April of this year.

Patient safety is a critical concern for all medical and pharmaceutical manufacturers, which is why the quality of the supply chain – including testing services – is so important​,” said Dr Chris Berry, Manager, Medical Device Physical Testing, Smithers Pira, in a press release.

cGMP services available at the facility include design verification testing, stability studies, batch release, and post market surveillance

Related news

Show more

Related products

show more

Transforming Clinical Development

Transforming Clinical Development

PerkinElmer | 01-Jun-2021 | Technical / White Paper

The estimated cost of bringing a drug to market in the U.S. according to JAMA is $1 billion.1 The extreme cost of clinical trials urge biopharmaceutical,...

Q&A: Effective Drug Product Process Development

Q&A: Effective Drug Product Process Development

Catalent Pharma Solutions | 14-Jan-2021 | Insight Guide

In this Q&A, a Catalent Biologics expert shares his expertise with drug product process development challenges, risks and how to mitigate them, the...

Why Blister Packaging: Things to Consider

Why Blister Packaging: Things to Consider

Catalent Pharma Solutions | 03-Dec-2020 | Insight Guide

The decision to use blister packaging for either clinical trials or commercial drug manufacturing comes with a host of factors to consider. Pharmaceutical...

Related suppliers

Follow us


View more